Cite
HARVARD Citation
Ryan, C. et al. (2018). Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis. British journal of dermatology. pp. 844-852. [Online].